AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
BROLUCIZUMAB in Zimbabwe
1 product registered with MCAZ — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| PAGENAX SOLUTION; INJECTION | 2023/9.7/6389 | NOVARTIS OVERSEAS INVESTMENTS AG | active | 23 Mar 2028 |
BROLUCIZUMAB — MCAZ Registration Details
MCAZ (Zimbabwe) has 1 registered product containing BROLUCIZUMAB, of which 1 is currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track BROLUCIZUMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.